This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Roggeband, R Articles by Basketter, D A Search for Related Content PubMed PubMed Citation Articles by Roggeband, R Articles by Basketter, D A Social Bookmarking                         What's this?

Human volunteer studies; a consumer products company view

V Scailteur

Procter & Gamble Eurocor, Temselaan 100, 1853 Strombeek-Bever, Belgium

D A Basketter

Safety and Environmental Assurance Centre Toxicology Unit, Unilever Research, Sharnbrook, UK

The term ‘contact dermatitis’ refers to a range of adverse effects whose causation is quite varied. Manufacturers of consumer products have an important responsibility to minimise the extent to which their products cause such skin reactions. In meeting this responsibility, use may be made of humans, e.g. in studies related to skin irritation, to try to ensure the highest possible safety standards are achieved. The purpose of this short review paper is to outline the principles that must be followed before initiating studies with human volunteers. In addition, these principles are considered in the context of European legislation on chemicals and preparations.

Key Words: human testing • ethics • risk assessment • good clinical practice • European legislation on chemicals and preparations

Human & Experimental Toxicology, Vol. 18, No. 10, 591-593 (1999)
DOI: 10.1191/096032799678839491


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. de Moraes, M. Bezerra, F. Bezerra, R. de Moraes, P. Cavalcanti, C. Uchoa, F. Lima, and M Odorico de Moraes Safety evaluation of Elixir paregorico(R) in healthy volunteers: a phase I study Human and Experimental Toxicology, October 1, 2008; 27(10): 751 - 756. [Abstract] [PDF]